Abstract
A new series of N'-substituted benzylidene-2-(4-oxo-2-phenyl-1,4-dihydroquinazolin-3(2H)-yl)acetohydrazide (5a-5h) has been synthesized, characterized by FT-IR, NMR spectroscopy and mass spectrometry and tested against human monoamine oxidase (MAO) A and B. Only (3-methoxy-4-hydroxy)benzoyl substituted compounds gave submicromolar inhibition of MAO-A and MAO-B. Changing the phenyl substituent to methyl on the unsaturated quinazoline ring (12a-12d) decreased inhibition but a less flexible linker (14a-14d) resulted in selective micromolar inhibition of hMAO B providing insight for ongoing design.
| Original language | English |
|---|---|
| Article number | 200050 |
| Number of pages | 18 |
| Journal | Royal Society Open Science |
| Volume | 7 |
| DOIs | |
| Publication status | Published - 22 Apr 2020 |
Keywords
- Structure-activity relationships
- Quinazoline analogues
- Antidepressant
- Monoamine oxidase inhibitors
Fingerprint
Dive into the research topics of 'Design, synthesis, molecular modelling and in vitro screening of monoamine oxidase inhibitory activities of novel quinazolyl hydrazine derivatives'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver